Aussies follow the US’s lead in treating hard-to-reach patients
![Telehealth](https://www.ausdoc.com.au/wp-content/uploads/2022/08/telehealth-istock-1141320648-1.jpg)
Direct-acting antivirals have been a game-changer in hepatitis C treatment, providing fresh hope for the 180,000 Australians estimated to be living with the chronic disease.
Despite the agents’ success — a cure rate above 95% — challenges remain in treating difficult-to-access populations such as IV drug users, people with psychiatric comorbidities and Indigenous Australians.